Sohm, Inc. (SHMN)
Sohm, Inc. is a healthcare company focused on generic and private label pharmaceuticals. Through its operations, the company develops, manufactures, markets, and distributes products in the United States, including analgesics, antibiotics, anti-cold medicines, and anti-inflammatory drugs. Its portfolio also includes over-the-counter products, cosmeceuticals, and nutraceuticals, and it exports products as part of its business. In addition, Sohm has a collaboration agreement with Coastar Therapeutics aimed at advancing genome editing using red blood cell membrane derived carriers and genome editing technology. Founded in 2005, the company is based in Corona, California. The listed security is common stock on OTC Markets under the symbol SHMN.
Jump directly to the stock analysis sections supported by the latest available data.
| Ticker | Fair Value | Analyst Price Target | Analyst Target Upside/Downside | Overall Financial Health | Dividend Yield | Market Cap |
|---|---|---|---|---|---|---|
|
OTC-SHMN
|
Not available
|
Not available
|
Not available
|
Good
|
0.0%
|
2.606 M
|